Correlation Between Regencell Bioscience and Veritas Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Regencell Bioscience and Veritas Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regencell Bioscience and Veritas Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regencell Bioscience Holdings and Veritas Pharma, you can compare the effects of market volatilities on Regencell Bioscience and Veritas Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regencell Bioscience with a short position of Veritas Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regencell Bioscience and Veritas Pharma.

Diversification Opportunities for Regencell Bioscience and Veritas Pharma

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Regencell and Veritas is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Regencell Bioscience Holdings and Veritas Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Veritas Pharma and Regencell Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regencell Bioscience Holdings are associated (or correlated) with Veritas Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Veritas Pharma has no effect on the direction of Regencell Bioscience i.e., Regencell Bioscience and Veritas Pharma go up and down completely randomly.

Pair Corralation between Regencell Bioscience and Veritas Pharma

If you would invest  0.15  in Veritas Pharma on March 4, 2024 and sell it today you would earn a total of  0.00  from holding Veritas Pharma or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy95.24%
ValuesDaily Returns

Regencell Bioscience Holdings  vs.  Veritas Pharma

 Performance 
       Timeline  
Regencell Bioscience 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Regencell Bioscience Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Regencell Bioscience is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Veritas Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Veritas Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Veritas Pharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Regencell Bioscience and Veritas Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Regencell Bioscience and Veritas Pharma

The main advantage of trading using opposite Regencell Bioscience and Veritas Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regencell Bioscience position performs unexpectedly, Veritas Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Veritas Pharma will offset losses from the drop in Veritas Pharma's long position.
The idea behind Regencell Bioscience Holdings and Veritas Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings